1
|
Kilbile J, Sapkal SB, Renzi G, D’Agostino I, Cutarella L, Mori M, De Filippis B, Islam I, Massardi ML, Somenza E, Ronca R, Tamboli Y, Carta F, Supuran CT. Novel 2,4-Dichloro-5-sulfamoylbenzoic Acid Oxime Esters: First Studies as Potential Human Carbonic Anhydrase Inhibitors. ACS Med Chem Lett 2024; 15:972-978. [PMID: 38894925 PMCID: PMC11181484 DOI: 10.1021/acsmedchemlett.4c00206] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2024] [Revised: 05/18/2024] [Accepted: 05/21/2024] [Indexed: 06/21/2024] Open
Abstract
In this study, a focused library of oxime ester derivatives of 2,4-dichloro-5-sulfamoylbenzoic acid (lasamide) containing Schiff bases was synthesized and tested in vitro for their ability to inhibit the cytosolic human carbonic anhydrases (hCAs) I and II, as well as the transmembrane and tumor-associated IX and XII isoforms. As a result, we obtained a first line of knowledge on lasamide derivatives potentially useful for development as CA inhibitors (CAIs). In particular, we focused our attention on the derivative 11, which was selective toward hCAs IX and XII over the cytosolic isoenzymes. An in silico study was conducted to assess the binding mode of 11 within hCAs IX and XII. Also, antiproliferative assays highlighted promising derivatives. The data obtained in this study are currently in use for the development of better-performing compounds on the tumor-associated isoforms.
Collapse
Affiliation(s)
- Jaydeo
T. Kilbile
- Department
of Chemistry, School of Basic and Applied Sciences, MGM University, Chhatrapati Sambhajinagar, 431003 Maharashtra, India
| | - Suryakant B. Sapkal
- Department
of Chemistry, School of Basic and Applied Sciences, MGM University, Chhatrapati Sambhajinagar, 431003 Maharashtra, India
| | - Gioele Renzi
- NEUROFARBA
Department, Sezione di Scienze Farmaceutiche e Nutraceutiche, University of Florence, Sesto Fiorentino, 50019 Florence, Italy
| | - Ilaria D’Agostino
- NEUROFARBA
Department, Sezione di Scienze Farmaceutiche e Nutraceutiche, University of Florence, Sesto Fiorentino, 50019 Florence, Italy
- Department
of Pharmacy, University of Pisa, 56126 Pisa, Italy
| | - Luigi Cutarella
- Department
of Biotechnology, Chemistry and Pharmacy, University of Siena, 53100 Siena, Italy
| | - Mattia Mori
- Department
of Biotechnology, Chemistry and Pharmacy, University of Siena, 53100 Siena, Italy
| | - Barbara De Filippis
- Department
of Pharmacy “G. d’Annunzio”, University of Chieti-Pescara, 66100 Chieti, Italy
| | - Imadul Islam
- King
Abdullah
International Medical Research Center (KAIMRC), King Saud Bin Abdulaziz University for Health Sciences, Ministry
of National Guard-Health Affairs, Riyadh 14811, Saudi Arabia
| | - Maria Luisa Massardi
- Department
of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy
| | - Elena Somenza
- Department
of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy
| | - Roberto Ronca
- Department
of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy
| | - Yasinalli Tamboli
- King
Abdullah
International Medical Research Center (KAIMRC), King Saud Bin Abdulaziz University for Health Sciences, Ministry
of National Guard-Health Affairs, Riyadh 14811, Saudi Arabia
| | - Fabrizio Carta
- NEUROFARBA
Department, Sezione di Scienze Farmaceutiche e Nutraceutiche, University of Florence, Sesto Fiorentino, 50019 Florence, Italy
| | - Claudiu T. Supuran
- NEUROFARBA
Department, Sezione di Scienze Farmaceutiche e Nutraceutiche, University of Florence, Sesto Fiorentino, 50019 Florence, Italy
| |
Collapse
|
2
|
Persaud KE, Sahu RR, Neary MC, Kapdi AR, Lakshman MK. Two short approaches to the COVID-19 drug β-D- N4-hydroxycytidine and its prodrug molnupiravir. Org Biomol Chem 2024; 22:735-740. [PMID: 38168802 DOI: 10.1039/d3ob02039h] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2024]
Abstract
Molnupiravir, the prodrug for β-D-N4-hydroxycytidine (NHC), is marketed by Merck as Lagevrio™ against mild-moderate COVID-19, under FDA emergency use authorization. It is the first oral drug against the disease. This work describes two synthetic approaches to NHC and molnupiravir by amide activation in uridine with a peptide-coupling agent and with a 4-chloropyrimidinone nucleoside intermediate.
Collapse
Affiliation(s)
- Kevin E Persaud
- Department of Chemistry and Biochemistry, The City College of New York, 160 Convent Avenue, New York, NY 10031, USA.
| | - Rajesh R Sahu
- Department of Chemistry, Institute of Chemical Technology, Nathalal Parekh Road, Matunga, Mumbai 400019, India
| | - Michelle C Neary
- Department of Chemistry, Hunter College, 695 Park Avenue, New York, NY 10065, USA
| | - Anant R Kapdi
- Department of Chemistry, Institute of Chemical Technology, Nathalal Parekh Road, Matunga, Mumbai 400019, India
| | - Mahesh K Lakshman
- Department of Chemistry and Biochemistry, The City College of New York, 160 Convent Avenue, New York, NY 10031, USA.
| |
Collapse
|
3
|
Weigelt V, Vogl S, Schmidt J, Thomas A. A Triphenylphosphine-Based Microporous Polymer for a Wittig Reaction Cycle in the Solid State. Angew Chem Int Ed Engl 2023; 62:e202307818. [PMID: 37460443 DOI: 10.1002/anie.202307818] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2023] [Accepted: 07/14/2023] [Indexed: 08/24/2023]
Abstract
The Wittig reaction is a key step in industrial processes to synthesise large quantities of vitamin A and various other important chemicals that are used in daily life. This article presents a pathway to achieve the Wittig reaction in a solid network. A highly porous triphenylphosphine-based polymer was applied as a solid Wittig reagent that undergoes, in a multi-step cycle, in total six post-synthetic modifications. This allowed for regeneration of the solid Wittig reagent and reuse for the same reaction cycle. Of particular industrial relevance is that the newly developed material also enables a simple way of separating the product by filtration. Therefore, additional costly and difficult separation and purification steps are no longer needed.
Collapse
Affiliation(s)
- Vincent Weigelt
- Department of Chemistry/Functional Materials, Technische Universität Berlin, Hardenbergstraße 40, 10623, Berlin, Germany
| | - Sarah Vogl
- Department of Chemistry/Functional Materials, Technische Universität Berlin, Hardenbergstraße 40, 10623, Berlin, Germany
| | - Johannes Schmidt
- Department of Chemistry/Functional Materials, Technische Universität Berlin, Hardenbergstraße 40, 10623, Berlin, Germany
| | - Arne Thomas
- Department of Chemistry/Functional Materials, Technische Universität Berlin, Hardenbergstraße 40, 10623, Berlin, Germany
| |
Collapse
|
4
|
Tamboli Y, Kilbile JT, Deshmukh V, Rane V, Tadiparthi R, Yeole R, Merwade AY. Process Development and Scale-Up of the Novel β-Lactamase Inhibitor WCK 6395. Org Process Res Dev 2023. [DOI: 10.1021/acs.oprd.2c00349] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/06/2023]
Affiliation(s)
- Yasinalli Tamboli
- Wockhardt Research Centre, D-4, MIDC, Chikalthana, Aurangabad 431006, India
- King Abdullah International Medical Research Center (KAIMRC), Ministry of National Guard-Health Affairs, King Saud Bin Abdulaziz University for Health Sciences, Riyadh 14811, Saudi Arabia
| | - Jaydeo T. Kilbile
- Wockhardt Research Centre, D-4, MIDC, Chikalthana, Aurangabad 431006, India
| | - Vikas Deshmukh
- Wockhardt Research Centre, D-4, MIDC, Chikalthana, Aurangabad 431006, India
| | - Vipul Rane
- Wockhardt Research Centre, D-4, MIDC, Chikalthana, Aurangabad 431006, India
| | | | - Ravindra Yeole
- Wockhardt Research Centre, D-4, MIDC, Chikalthana, Aurangabad 431006, India
| | - Arvind Y. Merwade
- Wockhardt Research Centre, D-4, MIDC, Chikalthana, Aurangabad 431006, India
| |
Collapse
|
5
|
Tamboli Y, Kilbile JT, Merwade AY. Large-Scale Amide Coupling in Aqueous Media: Process for the Production of Diazabicyclooctane β-Lactamase Inhibitors. Org Process Res Dev 2023. [DOI: 10.1021/acs.oprd.2c00299] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
Affiliation(s)
- Yasinalli Tamboli
- Wockhardt Research Centre, D-4, MIDC, Chikalthana, Aurangabad431 006, India
| | - Jaydeo T. Kilbile
- Wockhardt Research Centre, D-4, MIDC, Chikalthana, Aurangabad431 006, India
| | - Arvind Y. Merwade
- Wockhardt Research Centre, D-4, MIDC, Chikalthana, Aurangabad431 006, India
| |
Collapse
|
6
|
Qu B, Lee J, Wu L, Saha AK, Li G, Xu Y, Tan Z, Brazzillo J, Haddad N, Pennino S, Rodriguez S, Lorenz JC, Frutos R, Sidhu KPS, Wang XJ, Zhang Y, Senanayake CH, Song JJ. Scalable Process of Spiro(cyclopropane)oxazepane Pyridine Carboxylic Acid through Kulinkovich, Mitsunobu, and Pd-Catalyzed Intramolecular C–N Coupling. Org Process Res Dev 2022. [DOI: 10.1021/acs.oprd.2c00221] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Bo Qu
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| | - Jaehee Lee
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| | - Lifen Wu
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| | - Anjan K. Saha
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| | - Guisheng Li
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| | - Yibo Xu
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| | - Zhulin Tan
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| | - Jason Brazzillo
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| | - Nizar Haddad
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| | - Scott Pennino
- Material and Analytical Sciences, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| | - Sonia Rodriguez
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| | - Jon C. Lorenz
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| | - Rogelio Frutos
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| | - Kanwar P. S. Sidhu
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| | - Xiao-Jun Wang
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| | - Yongda Zhang
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| | - Chris H. Senanayake
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| | - Jinhua J. Song
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| |
Collapse
|
7
|
Hergueta AR. Easy Removal of Triphenylphosphine Oxide from Reaction Mixtures by Precipitation with CaBr 2. Org Process Res Dev 2022. [DOI: 10.1021/acs.oprd.2c00104] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|